Compound Screening TRIZ Cases

Isolating immune-active T cells via MHC multimers and sequencing their TCRs to identify cancer-specific antigens for personalized therapy.

A screening method uses segmented voltage-gated ion channels to detect modulating compounds through patch-clamp measurements.

A VeraTag assay uses molecular tags and cleavage-inducing moieties to detect cell surface moiety clustering.

Plasma exchange chromatography isolates Aegyptin, which unwinds collagen triple helices to inhibit platelet aggregation without bleeding risks.

Dynamic regulation of HSF1 acetylation balances cellular protection with growth by resolving proteostasis dysfunction.

Polymerase chain reaction amplifies saxitoxin gene sequences to identify cyanotoxic organisms, replacing slow culture methods with rapid genetic detection.

Epigenome-modifying agents prevent cellular degradation of misfolded proteins, restoring functionality in genetic muscular diseases.

Inducing CD16 expression in MonoMac-1 monocytes via sequential cytokine treatment to replace inconsistent primary cell models for reliable drug screening.

An inducible reconstitution system enables real-time quantitative kinetic analysis of intramembrane proteases within lipid bilayers.

A 3D printed bladder cancer mimic replicates the in vivo tumor microenvironment using stacked cell layers.

Peptides bind WW domains to relieve auto-inhibition of Nedd4-family ligases, reducing pro-inflammatory cytokine production.

Genetically encoded biosensors detect intracellular voltage changes in human cell models, resolving limited tissue penetration of traditional indicators.

Peptide mimotopes replace complex transmembrane proteins to detect CLDN18.2 antibodies, reducing development time and cost.

Identified agonists for human bitter taste receptors modulate transduction pathways to alter sensory perception.

Heat shock-treated stem cell exosomes improve skin texture and reduce wrinkles by stimulating collagen production without irritation.

Administering agents that enhance Nix and GABARAP-L1 activity removes damaged mitochondria, addressing side effects of dopamine replenishment therapies.

Determining the androgen receptor to estrogen receptor ratio in breast cancer tissue samples.

Antibody binds the C-terminal lysine residue of the T14 peptide, neutralizing toxic effects that existing amyloid-targeting therapies fail to address.

Linkers attach diverse glycans to substrates, resolving immobilization difficulties caused by chemical variability.

A microgravity-based method determines drug suitability by comparing RNA and protein expression in simulated disease conditions.

Glycoenzyme inhibitors modulate globoseries glycosphingolipid synthesis to overcome weak T cell-dependent immune responses in carbohydrate-based vaccines.

Live attenuated bacteria secrete protease inhibitors to reduce inflammation while minimizing off-target toxicity.

Monoclonal antibodies targeting AnnexinA2 inhibit tumor invasion and metastasis in pancreatic ductal adenocarcinoma.

Segmented indirect three-dimensional co-culture system maintains tumor cell viability through soluble factor diffusion.

Implanting dissociated epidermal and dermal cells directly into wounds eliminates complex in vitro follicle formation while producing functional tissue.

Angiogenin fragments activate endogenous proteases to expand Schlemm's canal, reducing intraocular pressure while protecting retinal ganglion cells.

Screen rinse-off personal care compositions using skin explants to measure moisture and cell proliferation, replacing non-predictive in vitro methods.

Compounds prevent beta-amyloid inhibition of PDK1-dependent Akt activation, reversing insulin resistance and neuronal degeneration in Alzheimer's disease.

Screening methods identify test compounds binding to centrosomal proteins, enabling targeted regulation of insulin secretion for diabetes treatment.

Orthogonal tRNA systems incorporate non-natural amino acids to overcome limited functional diversity while maintaining protein structure stability.

Bioengineered hydrogel microwell arrays replace Matrigel to eliminate culture artifacts while maintaining high-throughput screening capability.

Segmenting hibernator gene expression profiles across torpor cycles isolates genetic mechanisms providing transient disease resistance.

Anti-APOA2 antibody recognizes apolipoprotein A2 to treat inflammatory diseases.

Anti-CD39L3 antibodies enable non-invasive quantification of beta cell mass, resolving the trade-off between measurement precision and surgical invasiveness.

HMGB1 proteins released from necrotic tissue recruit bone marrow stem cells, resolving the unknown mobilization mechanism for effective tissue regeneration.

Mono-SMAD differentiation of pluripotent stem cells generates midbrain dopaminergic progenitor cells with superior engraftment properties.

Replacing manual plaque counting with automated luminescence detection reduces turnaround time to under two days while maintaining diagnostic specificity.

Antibodies bind neo-C-terminal beta-amyloid fragments to detect pathological aggregates, resolving specificity issues in early Alzheimer's diagnosis.